Beijing, China — China has announced new measures limiting the participation of European Union (EU) enterprises in government procurement of medical devices. The Ministry of Finance detailed on Thursday that for purchases exceeding 45 million yuan (about $6.29 million), EU companies (excluding EU-funded enterprises in China) will be excluded if imported products are deemed necessary after legal procedures.
The ministry clarified that this threshold applies regardless of whether the procurement involves single-unit purchases, bulk purchases, or various types of medical devices. EU-funded enterprises operating in China can still participate in these projects. However, if their products include medical devices imported from the EU, the value of those imports must not exceed 50% of the total contract value.
It’s important to note that procurement by China’s state-owned enterprises is not classified under government procurement, and these new measures do not apply to them.
A spokesperson for China’s Ministry of Commerce stated on Sunday that the European Commission had introduced measures on June 20, 2023, to restrict Chinese enterprises and products from participating in the EU’s public procurement of medical devices. The spokesperson expressed disappointment, noting that despite China’s efforts and willingness to resolve differences through dialogue and consultation, the EU has continued to implement restrictive measures, creating new protectionist barriers.
"Therefore, China has no choice but to take reciprocal restrictive measures to safeguard the legitimate rights and interests of Chinese enterprises and to maintain a fair competition environment," the spokesperson added.
This development marks a significant moment in the ongoing trade relations between China and the EU, especially in the healthcare sector. Young entrepreneurs and stakeholders in the global south are watching closely, as these measures could impact international cooperation and market dynamics.
